Oramed Pharmaceuticals
ORMP
#9089
Rank
NZ$0.20 B
Marketcap
NZ$5.22
Share price
4.66%
Change (1 day)
22.98%
Change (1 year)

Earnings for Oramed Pharmaceuticals (ORMP)

Earnings in 2025 (TTM): -NZ$8.6 Million

According to Oramed Pharmaceuticals's latest financial reports the company's current earnings are NZ$2 Million. In 2024 the company made an earning of NZ$0.6 Million a decrease over its 2023 earnings that were of NZ$12.25 Million. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Oramed Pharmaceuticals from 2006 to 2025

Annual earnings

Year Earnings Change
2025 (TTM) -NZ$8.6 Million-1514.88%
2024 NZ$0.6 M-95.05%
2023 NZ$12.25 M-119.45%
2022 -NZ$63.02 Million39.17%
2021 -NZ$45.28 Million73.93%
2020 -NZ$26.04 Million18.53%
2019 -NZ$21.97 Million-16.62%
2018 -NZ$26.35 Million38.32%
2017 -NZ$19.05 Million12.51%
2016 -NZ$16.93 Million25.01%
2015 -NZ$13.54 Million18.18%
2014 -NZ$11.46 Million39.72%
2013 -NZ$8.2 Million46.4%
2012 -NZ$5.61 Million128.32%
2011 -NZ$2.46 Million-51.47%
2010 -NZ$5.06 Million35.21%
2009 -NZ$3.74 Million
2007 -NZ$5.88 Million607.04%
2006 -NZ$0.84 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Ultragenyx Pharmaceutical
RARE
-NZ$0.9 Billion 12,138.44%๐Ÿ‡บ๐Ÿ‡ธ USA
Novo Nordisk
NVO
NZ$35.86 B-491,978.24%๐Ÿ‡ฉ๐Ÿ‡ฐ Denmark
Sanofi
SNY
NZ$15.65 B-214,830.06%๐Ÿ‡ซ๐Ÿ‡ท France
Compugen
CGEN
-NZ$47.42 Million 550.33%๐Ÿ‡ฎ๐Ÿ‡ฑ Israel
Lexicon Pharmaceuticals
LXRX
-NZ$0.12 Billion 1,518.17%๐Ÿ‡บ๐Ÿ‡ธ USA